Investigation of a High-Dose pH-Dependent-Release Mesalazine on the Induction of Remission in Active Crohn’s Disease

Drugs in R and D - United Kingdom
doi 10.1007/s40268-015-0113-9
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Mesalazine Release From a pH Dependent Formulation: Effects of Omeprazole and Lactulose Co-Administration

British Journal of Clinical Pharmacology
Pharmacology
1998English

Dietary Treatment of Active Crohn’s Disease

Nursing standard (Royal College of Nursing (Great Britain) : 1987)
Medicine
1990English

Crohn’s Disease Remission With a Plant-Based Diet: A Case Report

Nutrients
NutritionFood ScienceDietetics
2019English

Glutamine for Induction of Remission in Crohn's Disease

Cochrane Database of Systematic Reviews
2016English

Interventions for Maintenance of Surgically Induced Remission in Crohn’s Disease: A Network Meta-Analysis

Cochrane Database of Systematic Reviews
2019English

Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease

Gastroenterology
HepatologyGastroenterology
2019English

Design and Evaluation of Colon Targeted Dosage Form Containing Mesalazine Using pH Dependent Polymers

International Journal of Pharmaceutical Sciences and Drug Research
2017English

A Randomized Trial of High-Versus Conventional-Dose Cytarabine in Consolidation Chemotherapy for Adult De Novo Acute Myeloid Leukemia in First Remission After Induction Therapy Containing High-Dose Cytarabine

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Remission in Crohn’s Disease Is Accompanied by Alterations in the Gut Microbiota and Mucins Production

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy